Lee SJ - Search Results

1

Treatment of chronic graft-versus-host disease with clofazimine.

Lee SJ, Wegner SA, McGarigle CJ, Bierer BE, Antin JH. Lee SJ, et al. Blood. 1997 Apr 1;89(7):2298-302. Blood. 1997. PMID: 9116272 Free article. Clinical Trial.

2

Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.

Porter DL, Roth MS, Lee SJ, McGarigle C, Ferrara JL, Antin JH. Porter DL, et al. Among authors: lee sj. Bone Marrow Transplant. 1996 Nov;18(5):975-80. Bone Marrow Transplant. 1996. PMID: 8932854

3

Idiopathic thrombocytopenic purpura following allogeneic bone marrow transplantation--treatment with anti-D immunoglobulin.

Lee SJ, Churchill WH, Konugres A, Gilliland DG, Antin JH. Lee SJ, et al. Bone Marrow Transplant. 1997 Jan;19(2):173-4. doi: 10.1038/sj.bmt.1700634. Bone Marrow Transplant. 1997. PMID: 9116615

4

Graft-vs.-host disease.

Woo SB, Lee SJ, Schubert MM. Woo SB, et al. Among authors: lee sj. Crit Rev Oral Biol Med. 1997;8(2):201-16. doi: 10.1177/10454411970080020701. Crit Rev Oral Biol Med. 1997. PMID: 9167093 Review.

5

Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis.

Lee SJ, Kuntz KM, Horowitz MM, McGlave PB, Goldman JM, Sobocinski KA, Hegland J, Kollman C, Parsons SK, Weinstein MC, Weeks JC, Antin JH. Lee SJ, et al. Ann Intern Med. 1997 Dec 15;127(12):1080-8. doi: 10.7326/0003-4819-127-12-199712150-00005. Ann Intern Med. 1997. PMID: 9412310

6

Initial therapy for chronic myelogenous leukemia: playing the odds.

Lee SJ, Anasetti C, Horowitz MM, Antin JH. Lee SJ, et al. J Clin Oncol. 1998 Sep;16(9):2897-903. doi: 10.1200/JCO.1998.16.9.2897. J Clin Oncol. 1998. PMID: 9738555 Review.

7

Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation.

Lee SJ, Weller E, Alyea EP, Ritz J, Soiffer RJ. Lee SJ, et al. Blood. 1998 Oct 15;92(8):2725-9. Blood. 1998. PMID: 9763556 Free article.

8

The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia.

Lee SJ, Anasetti C, Kuntz KM, Patten J, Antin JH, Weeks JC. Lee SJ, et al. Blood. 1998 Dec 1;92(11):4047-52. Blood. 1998. PMID: 9834208 Free article.

9

Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.

Sehn LH, Alyea EP, Weller E, Canning C, Lee S, Ritz J, Antin JH, Soiffer RJ. Sehn LH, et al. J Clin Oncol. 1999 Feb;17(2):561-8. doi: 10.1200/JCO.1999.17.2.561. J Clin Oncol. 1999. PMID: 10080600 Clinical Trial.

10

Predicting costs of stem-cell transplantation.

Lee SJ, Klar N, Weeks JC, Antin JH. Lee SJ, et al. J Clin Oncol. 2000 Jan;18(1):64-71. doi: 10.1200/JCO.2000.18.1.64. J Clin Oncol. 2000. PMID: 10623694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,009 results

Search Page

Filters